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Background: In patients of tamponade, interim measures may occasionally be needed
when facilities for pericardial ﬂuid drainage are not immediately available. Intravas-
cular volume expansion is the most commonly advocated measure but with limited
scientiﬁc data.This study was undertaken to ascertain an optimum amount of ﬂuid that
can produce the maximum beneﬁt in tamponade patients.
Methods: Patients  16 years of age with large circumferential pericardial effusion,
and showing echocardiographic evidence of cardiac tamponade were included. He-
modynamically unstable patients; those with structural heart diseases; pregnant fe-
males and those undergoing hemodialysis were excluded. SBP and CO were measured
using Edwards Life Sciences Vigilance II monitor , Swan Ganz CCO catheter and
arterial access; at baseline and after each 250 ml of ﬂuid over 5 min (totalling to 1000
mL in 20 min). The entire ﬂuid was drained at the end of the procedure.
Results: A total of 28 patients constituted the study group; all of whom exhibited an
improvement in hemodynamic parameters (SBP, CO) with volume expansion. Sig-
niﬁcant (p< 0.05 ) increase in SBP, DBP, CO and CI values occurred upto 250-500 ml
bracket; above which the signiﬁcance was lost.
Conclusions: Rapid infusion of as little as 250 ml of intravenous normal saline may
improve the cardiac hemodynamics in a signiﬁcant proportion of tamponade patients.Angiography and QCA
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Background: Inaccurate lesion measurement and inappropriate stent length selection
can negatively affect clinical outcomes following coronary stent deployment. Mea-
surement errors resulting in longitudinal geographic miss or the use of inappropriately
long stents have been associated with restenosis and the need for target lesion
revascularization. This study evaluated interventional cardiologists’ (IC) ability to
measure lesions and select stent lengths.
Methods: This evaluationwas conducted as a prospective, online, interactive survey of 25
matched orthogonal angiographic images that were pre-scored using quantitative coronary
angiography (QCA). Participants provided estimates of lesion length and stent length se-
lection. These estimates were compared to the maximum QCA value. A 2-4 mm stent
overlap of both the proximal and distal lesion edgeswas considered to be optimal. Basedon
this, lesion lengths measurements>1 mm below and>4 mm above and stent lengths that
were less than4mmand>8mmfrom theQCAvaluewere considered to be short and long,
respectively. Five of the 25 images were repeated to assess intra-rater variability.
Results: Forty ICs participated. The results are summarized in Table 1. Accurate lesion
length measurement and stent length selection occurred in only 30.4% and 22.3% of
the cases, respectively. Stent length misses that would fail to cover the entire lesion
comprised 23.8% of the cases. Analysis of repeated images showed a>3mm difference
in 38.5% and 37.5% of length measurements and stent length selections, respectively.Table 1. Evaluator Lesion Length Measurement and Stent Length Selection
Relative to QCA
Short Accurate Long
Lesion Length Measurement 409 (51.1%) 243 (30.4%) 152 (19.0%)
47.6%, 54.6% 27.2%, 33.7% 16.3%, 21.9%
Stent Length Selection 440 (55.0%) 178 (22.3%) 182 (22.8%)
51.5%, 58.5% 19.4%, 25.3% 19.9%, 25.8%
N (percent of total)
95% conﬁdence interval
JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AngiograpConclusions: Manual assessment of the coronary lesion length has a high degree of
inter-rater and intra-rater variability, which may lead to inadequate stent selection and
lesion treatment. Employing methodology to improve the accuracy of lesion mea-
surement may improve patient outcomes.
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Background: Stent underexpansion and malapposition continue to be important
factors in suboptimal outcomes of stent treatment of obstructive coronary disease. It is
well established that stents rarely achieve intended post-implant diameters that would
be expected from the maximum applied pressure and the stent pressure-diameter
characteristics provided by the manufacturer. In human arteries, the restrictive forces
preventing the stent from fully expanding are attributed to the rigidity and heteroge-
neous composition of atherosclerotically damaged wall, calciﬁcations in particular.
We sought to examine the true in-vivo stent recoil in response to elastic forces posed
by healthy porcine arteries.
Methods: One hundred ﬁfty eight stents were implanted in coronary arteries in
swine model aiming at an 120% overstretch ratio. Final minimum stent diameter
(MSD) immediately post-deployment was measured by QCA (XIENCE¼39,
RESOLUTE¼41, OMEGA¼42), intravascular ultrasound (IVUS) (LIBERTE ¼23,
PROMUS ¼16) and optical coherence tomography (OCT) (XIENCE¼12). In 122
stents examined by QCA, minimum balloon diameter (MBD) during stent
deployment was also measured. For each stent, MSD was compared to the projected
diameter (PD) that the stent was to achieve per compliance chart at the pressure
used.
Results: The average MSD by QCA was 7.98.3% lower than the PD expected
from the compliance chart at the pressure used. IVUS and OCT demonstrated
similar deﬁcit of MSD in comparison to PD (7.15.7% by IVUS and 9.44.8% by
OCT). MBD was only 2.56.4% lower than PD, thus accounting for w1/3 of the
deﬁcit, while w2/3 was due to true recoil. Stent type, coronary branch location
(RCA, LAD or LCX), baseline artery size (reference diameter), tapering of the
stented segment and the actual overstretch ratio had no evident impact on the
magnitude of deﬁcit/recoil.
Conclusions: Elastic resistance of normal porcine coronary arteries is sufﬁcient to
induce acute stent recoil signiﬁcantly beyond the typical manufacturer’s claim of less
than 3% based on bench testing in air with no external resistance. As a consequence,
stents consistently achieve 7-10 % less than the predicted diameter, even in complete
absence of atherosclerosis.
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Background: The extent of coronary artery disease (CAD), as quantiﬁed by the
baseline SYNTAX Score (bSS) and the residual SS (rSS) after PCI, have been shown
to be associated with adverse ischemic outcomes in various studies. We sought to
quantify the proportion of CAD burden treated by PCI and to evaluate its impact on 1-
year adverse ischemic events, using a newly developed index (the SYNTAX
Revascularization Index; SRI).
Methods: The bSS and rSS from 2,681 angiograms from patients enrolled in the
prospective ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy)
trial were determined. The SRI was then calculated for each patient by the following
formula [1-(rSS/bSS)] x 100. Patients were then stratiﬁed and outcomes examined
according to the proportion of revascularized myocardium (SRI¼100% (complete
revascularization), 50-99% and < 50%).
Results: The mean bSS was 12.8  6.7, and after PCI the mean rSS was 5.6  2.2.
The SRI was 100% in 1079 patients (40.2%) 50-99% in 908 patients (33.9%), and <
50% in 694 patients (25.9%). One-year adverse outcomes, including death, were
inversely proportional to the SRI (Table). By multivariable analysis, SRI was found to
be an independent predictor of 1-year mortality (hazard ratio (HR) ¼ 0.48 [95%CI
0.24, 0.95], P¼0.03). An SRI cutoff of < 80% (present in 1287 (48.0%) of patients
after PCI) had the best prognostic accuracy for risk prediction of death (AUC 0.60,
[95%CI 0.53, 0.67] p¼0.004).hy and QCA B25
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: The SRI is a newly described method for quantifying the proportion of
CAD burden treated by PCI. Given its correlation with mortality, and pending external
validation, the SRI may be useful in assessing the degree of revascularization after
PCI, with SRI 80% a “reasonable” goal.One-year Outcomes According to SYNTAX Revascularization Index
SRI 100%
SRI 50-
99% SRI <50%
P-value all
groups
Death 15 (1.4) 24 (2.7) 25 (3.7) 0.009
Cardiac death 4 (0.4) 18 (2.0) 13 (1.9) 0.002
Myocardial infarction 75 (7.1) 97 (10.8) 71 (10.4) 0.006
Unplanned
revascularization
109 (11.0) 99 (11.4) 89 (13.4) 0.14
Deﬁnite/probable ST 12 (1.1) 17 (1.9) 13 (2.0) 0.29
Death/ myocardial
infarction
86 (8.2) 110 (12.3) 88 (12.9) 0.001
Major adverse cardiac
events
167 (16.4) 171 (19.2) 144 (21.3) 0.009
Data presented as n (%); Major adverse cardiac events (MACE) is the composite rate of death,
myocardial infarction, or unplanned revascularization. MI¼myocardial infarction;
SRI¼SYNTAX Revascularization Index; ST¼stent thrombosis.TCT-87
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Background: Women have greater morbidity and mortality after myocardial infarc-
tion (MI) than men. Whether this is due to more severe comorbidities or inherent
biologic differences is unsettled. Speciﬁcally, women have been shown to have higher
platelet reactivity, but whether a greater thrombotic tendency contributes to gender
differences in outcome is unknown.
Methods: Intraprocedural Thrombotic Events (IPTE), deﬁned as new/increasing
thrombus, abrupt vessel closure, no/slow reﬂow, or distal embolization, were evalu-
ated in 6,591 patients undergoing stenting in a pooled analysis from the ACUITY and
HORIZONS-AMI trials of patients with non-ST-segment elevation acute coronary
syndromes and ST-segment elevation MI. Quantitative coronary angiographic analysis
was blinded to treatment and outcomes.
Results: IPTE was identiﬁed in 507 patients (7.7%), with 119/1744 (6.8%) occurring
in women and 388/4847 (8.0%) in men (p¼0.12). Rates of MACE (Death, MI, un-
planned target lesion revascularization for ischemia) and major bleeding were higher
in women (p< 0.001) and in patients with IPTE (p< 0.001). However, the risk of
MACE associated with IPTE was nearly identical among women [HR (95%CI) ¼ 1.6
(1.0-2.4), p¼0.03] and men [HR ¼ 1.6 (1.2-2.0), p< 0.001] (Figure). Similar results
were found for major bleeding. There was no interaction between IPTE and gender for
1-year MACE (p¼0.99) and 30-day bleeding (p¼0.50).B26 JACC Vol 64/11/Suppl BConclusions: In acute coronary syndromes, IPTE is not uncommon and occurs at
similar frequency in both men and women. The adverse impact of IPTE on ischemic
and bleeding risk is also independent of sex.
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Background: Several studies showed peri-contrast staining (PSS) after silorimus-
eluting stent was be associated with target-lesion revascularization (TLR) and very
late stent thrombosis. However, the incidence and clinical sequela of PSS after second
generation DES implantation are unclear, so we retrospectively evaluate the clinical
outcomes.
Methods: This study consisted of de novo 2301 lesions in 1743 patients that were
treated with second generation DES (zotarolimus-eluting stent: ZES, everolimus-
eluting stent: EES, and biolimus-eluting stent: BES). They were evaluated by follow-
up angiography within 12 months after stent implantation, from April 2009 to
February 2013. We divided into PSS group and non-PSS group and compared the two
groups in clinical and angiographical outcomes.
Results:We had obtained 1872 lesions follow-up angiography. (81.3%) The mean
clinical follow up period was 61013 days. Baseline clinical and angiographic
characteristics were similar between the two groups. (N.S.) Late acquired PSS
was observed in 16 lesions (0.85%). In these lesions, 2 lesions (0.73%) were
observed in BES, 7 lesions (0.67%) were EES and 7 lesions (1.62%) were ZES.
(N.S.) Stent fracture (SF), tortuosity, and lesions with severe angulation (>45)
were more frequently observed in lesions with PSS than in lesions without PSS
(31.3% versus 1.1%, p< 0.0001, 12.5% versus 1.3%, p¼0.002, 18.8% versus
1.7%, p¼0.02). Cumulative incidence of TLR and MACE in the PSS group
was higher than that in the non-PSS group. ( 33.3% versus 5.4%, p¼0.003, and
41.7% versus 9.3%, p¼0.003). There was no signiﬁcant difference in late and
very late stent thrombosis between the two groups. (N.S.) After multivariable
analysis, CTO (OR: 4.07, 95% CI: 1.1 to 12.1, p¼0.04), and reference diameter
(>2.83mm) (OR: 4.17, 95% CI:1.5 to 12.4, p ¼ 0.005) were independent
predictors for PSS.
Conclusions: PSS after second generation DES was a rare phenomenon but appeared
to be associated with subsequent TLR.
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Background: The left ventricular global function index (LVGFI) is a novel indicator
of left ventricular performance. Its role in patients after acute myocardial infarction is
unknown. We sought to investigate the relationship between the LVGFI and infarct
characteristics as well as left ventricular ejection fraction in patients after acute ST-
segment elevation myocardial infarction (STEMI).
Methods: 226 patients with ﬁrst STEMI (mean age 57  11 years) were enrolled in
this observational study. All patients underwent cardiac magnetic resonance (CMR)
imaging within the ﬁrst week after STEMI. Infarct characteristics were determined
with the use of late gadolinium enhanced images. Left ventricular dimensions and
function were measured by cine true-FISP sequences.
Results: The mean LVGFI was 32  8 %. LVGFI was inversely related with peak
creatine kinase (r ¼ -0.46), peak cardiac troponin T (r ¼ -0.45) and CMR-determined
infarct size (r ¼ -0.42, all p < 0.001). Signiﬁcantly decreased LVGFI values were
also observed in patients with microvascular obstruction and anterior STEMI (all
p < 0.001). In addition, there was a strong correlation between LVGFI and left
ventricular ejection fraction (r ¼ 0.91, p < 0.001).
Conclusions: This study demonstrates that the LVGFI is signiﬁcantly associated
with infarct characteristics and left ventricular ejection fraction in patients after
acute STEMI. LVGFI is a useful functional parameter of the left ventricle.
Future studies are needed to evaluate its role as a prognostic marker in this
population.j September 13–17, 2014 j TCT Abstracts/Angiography and QCA
